Recruiting Thalassemia Studies in Stanford
About Thalassemia Clinical Trials in Stanford
Thalassemia is an inherited blood disorder causing the body to produce abnormal or insufficient hemoglobin. Severe forms (thalassemia major) require regular blood transfusions. Treatment includes transfusions, iron chelation therapy, and potentially curative gene therapy.
There are currently 1 thalassemia clinical trials recruiting participants in Stanford, CALIFORNIA. These studies are seeking a combined 665 participants. Research is being sponsored by Celgene. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thalassemia Clinical Trials in Stanford — FAQ
Are there thalassemia clinical trials in Stanford?
Yes, there are 1 thalassemia clinical trials currently recruiting in Stanford, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What thalassemia treatments are being tested?
The 1 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for thalassemia.
Data updated March 2, 2026 from ClinicalTrials.gov